SCHEMBL7823443

SCHEMBL7823443

CNc1cc(NS(=O)(=O)c2cccc(Cl)c2)cc(NC)n1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 10/20 0.61
▸ HTR6 P50406 1/20 0.59
▸ PKM P14618 1/20 0.58
▸ MAPT P10636 2/20 0.57
▸ LMNA P02545 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ EDNRB P24530 1/20 0.50
▸ EDNRA P25101 1/20 0.50
▸ SLC40A1 Q9NP59 1/20 0.50
▸ PIK3CD O00329 1/20 0.49
▸ PIK3CA P42336 1/20 0.49
▸ PIK3CB P42338 1/20 0.49
▸ PIK3CG P48736 1/20 0.49
▸ PTPN2 P17706 1/20 0.49
▸ PTPN1 P18031 1/20 0.49
▸ PTPN5 P54829 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7835675 0.83 HTR6 (0.61) PGRHTR6PKMMAPTLMNA
Hydrochloric Acid SCHEMBL7826198 0.82 HTR6 (0.71) HTR6PKMMAPTTDP1
SCHEMBL7824705 0.79 PGR (0.68) PGRPKMMAPTLMNATDP1
Hydrochloric Acid SCHEMBL7832910 0.79 TSHR (0.58) PGRHTR6SLC40A1PIK3CBPTPN2
SCHEMBL7826180 0.77 PGR (0.50) PGRHTR6PKMMAPTLMNA
SCHEMBL3756876 0.77 PGR (1.00) PGRPKMMAPTLMNATDP1
SCHEMBL679027 0.75 HTR6 (1.00) HTR6MAPTTDP1
SCHEMBL2371349 0.74 LMNA (0.61) PGRPKMMAPTLMNATDP1
SCHEMBL28400969 0.74 PGR (0.76) PGRPKMMAPTLMNATDP1
Hydrochloric Acid SCHEMBL8043492 0.74 HTR6 (0.97) HTR6MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815861-B1 Sulphonamides and their use HOFFMANN LA ROCHE (CH) 2001-09-19 — — EP disclosed
US-6030976-A SELECTIVE AFFINITY TO 5HT-6 RECEPTORS; CENTRAL NERVOUS SYSTEM DISORDERS; ALZHEIMER'S DISEASE, PSYCHOSES, SCHIZOPHRENIA, MANIC DEPRESSIONS, MEMORY DISORDERS, PARKINSON'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS AND HUNTINGTON'S DISEASE HOFFMAN-LA ROCHE INC. (US) 2000-02-29 — — US disclosed
US-5998665-A THERAPY FOR NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-12-07 — — US disclosed
US-5939451-A INDOL-4-YL-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-17 — — US disclosed
US-5932599-A 4-AMINO-N-(PYRIDINYL-4-YL)-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-03 — — US disclosed
EP-0815861-A1 Sulphonamides and their use F. HOFFMANN-LA ROCHE AG (CH) 1998-01-07 — — EP disclosed
Send feedback